Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Shinabro in Hand Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age of 40 years or older~* Osteoarthritis according to ACR 1990 criteria~* Mean joint visual analog pain score (VAS) \> 30mm in the preceding 48 hours~* Patients who are will to participate~Exclusion Criteria:~* Any prior surgery of hand joints~* prior history of Shinbaro use~* Intra-articular injection of glucocorticosteroid or hyaluronic acid in the preceding 3 months~* Pregnancy or active breast feeding~* Prior hypersensitivity reaction to herbal medications~* AST or ALT elevation \> 3 of upper normal limit~* GRF (MDRD) \< 30 mg/min/1.73m2~* Nephrotic syndrome, other signficant kidney disease~* Patients who seem not to tolerate the study at investigator's discretion~* Patients who refuse to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo 2 capsules, twice daily, for 12 weeks.
- Shinbaro (Type: ACTIVE_COMPARATOR): Shinbaro, 2 capsules (300mg), twice daily, for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).